EUVIMEDEUVIMED entdecken
Open Access

Cystic Fibrosis Screen Positive, Inconclusive Diagnosis Genotypes in People with Cystic Fibrosis from the U.S. Patient Registry

Danieli B Salinas, Choo Phei Wee, Barbara Bailey, Karen Raraigh, Douglas Conrad

Annals of the American Thoracic Society · 01.04.2023 · 20 (4) · 523-531

DOI: 10.1513/annalsats.202201-024oc ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of the American Thoracic Society, online erschienen am 01.04.2023. Verfasst von Danieli B Salinas und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Pulmonology, Department of Pediatrics, Children's Hospital Los Angeles, and. Hauptthemen laut MEDLINE: Cystic Fibrosis. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, Cystic Fibrosis Foundation, National Center for Advancing Translational Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rationale

Variants within the cystic fibrosis (CF) transmembrane conductance regulator gene, CFTR, that are of unknown significance or are categorized as non–CF causing may be observed in persons with CF. These variants are frequently detected in children with inconclusive newborn screen results and, in some cases, may be associated with a benign presentation in early childhood that progresses to a CF phenotype later in life.

Objectives

To analyze data from individuals enrolled in the U.S. Cystic Fibrosis Foundation Patient Registry who have received a diagnosis of CF and who have variants found in a population of children with a CF screen positive, inconclusive diagnosis (CFSPID).

Methods

This retrospective review analyzed registry data from individuals with a diagnosis of CF who also harbor one or more variants of interest because of their frequency within a CFSPID population and/or their interpretation as non–CF causing. Three groups were defined by the number of CF-causing variants identified (CF-Cx2, CF-Cx1, and CF-Cx0), which were reported in addition to the variant(s) of interest. Multivariate quantile regression modeling of the outcome for forced expiratory volume in 1 second (FEV1) generated a disease severity score for each person determined by six selected variables. Median scores were calculated for the three groups.

Results

Patients carrying one CF-causing variant and at least one variant of interest (CF-Cx1) had higher median disease severity scores compared with those carrying CF-Cx2, suggesting a milder phenotype (P < 0.05). However, there was no statistically significant difference in scores between CF-Cx2 and the two other groups combined (CF-Cx1 and CF-Cx0; P = 0.33). Analysis revealed that the CF-Cx1 and CF-Cx0 groups, when compared with the CF-Cx2 group, had later median diagnoses (8 years vs. newborn; P < 0.0001), lower median sweat chloride (48 mmol/L vs. 94.5 mmol/L; P < 0.0001), lower prevalence of pancreatic insufficiency (29% vs. 78%; P < 0.0001), and higher median FEV1% predicted (95% vs. 87%; P = 0.0002).

Conclusions

Individuals with CF who have specific variants frequently identified in children with CFSPID have a similar range of disease severity scores compared with those who have two CF-causing variants, but a milder phenotype overall. Variants that should be given careful scrutiny because of their high prevalence are G576A+R668C, T854T, R75Q, F1052V, R1070W, R31C, and L967S.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisChild, PreschoolHumansInfant, NewbornNeonatal ScreeningCystic Fibrosis Transmembrane Conductance RegulatorGenotypePhenotypeRegistriesMutation

Stichwörter der Autor:innen

CFTR variants of unknown clinical significancenewborn screeningnon–CF-causing mutationsquantile regressionseverity score

Substanzen

Cystic Fibrosis Transmembrane Conductance Regulator

Autor:innen und Institutionen

  • Division of Pediatric Pulmonology, Department of Pediatrics, Children's Hospital Los Angeles, and.
  • Southern California Clinical and Translational Science Institute, Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, California.
  • Department of Mathematics and Statistics, San Diego State University, San Diego, California.
  • Department of Genetic Medicine, Johns Hopkins University, Baltimore, Maryland; and.
  • Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of California, San Diego, San Diego, California.

Förderung

  • NCATS NIH HHS
  • Cystic Fibrosis Foundation
  • National Center for Advancing Translational Science

Zitieren

APA

Salinas, D. B., Wee, C. P., Bailey, B., Raraigh, K., & Conrad, D. (2023). Cystic Fibrosis Screen Positive, Inconclusive Diagnosis Genotypes in People with Cystic Fibrosis from the U.S. Patient Registry. Annals of the American Thoracic Society, 20(4), 523-531. https://doi.org/10.1513/annalsats.202201-024oc

Vancouver

Salinas DB, Wee CP, Bailey B, Raraigh K, Conrad D. Cystic Fibrosis Screen Positive, Inconclusive Diagnosis Genotypes in People with Cystic Fibrosis from the U.S. Patient Registry. Annals of the American Thoracic Society. 2023;20(4):523-531. doi:10.1513/annalsats.202201-024oc

BibTeX
@article{Salinas2023,
  author = {Salinas, Danieli B and Wee, Choo Phei and Bailey, Barbara and Raraigh, Karen and Conrad, Douglas},
  title = {Cystic Fibrosis Screen Positive, Inconclusive Diagnosis Genotypes in People with Cystic Fibrosis from the U.S. Patient Registry},
  journal = {Annals of the American Thoracic Society},
  year = {2023},
  volume = {20},
  number = {4},
  pages = {523--531},
  doi = {10.1513/annalsats.202201-024oc}
}
Kostenlos starten →